Skip to main content

Large Employers Seeing an Increase in Cost to Treat Worker Opioid Misuse

According to a recent study by the Kaiser Family Family Foundation, large employers are currently experience a large increase in costs related to treating opioid addiction and overdoses for workers and their families. This comes despite a decrease in opioid prescriptions and overall opioid use being down. The cost of treatment is rising as well, the annual inpatient cost for opioid addiction treatment averaged $16,104 in 2016 up from $5,809 in 2006. "About four in ten people addicted to opioids are covered by private health insurance and Medicaid covers a similarly large share. Despite declining rates of opioid prescribing to those with employer coverage, spending on treatment for opioid addiction and overdose has increased rapidly, potentially tied to growing illicit use and increased awareness of opioid addiction. Opioid addiction and overdose treatment – the bulk of which is for dependents of employees – represents a small but growing share of overall employer health spending," the study states. Read the full study HERE.

Popular posts from this blog

PHOTOS: MMC Through the Years

Mobile Medical Corporation (MMC) is excited to be celebrating our 30th Anniversary in 2020! MMC was founded on June 21, 1990. Check out some photos as we have grown over the years!            

Synthetic Marijuana Making Local and National Headlines

Synthetic Marijuana, also known as "K-2" or "Spice" is a mixture of common herbs sprayed with synthetic chemicals that mirror the high of Marijuana. The synthetic product is sold as incense in head shops, tobacco stores and convenient stores. So far, twelve states have banned the sale of Synthetic Marijuana - (Kansas, Georgia, Alabama, Tennessee, Missouri, Louisiana, Mississippi, Arkansas, Oregon, Illinois, Michigan, and Kentucky). The American Association of Poison Control Centers reported that within the past year there have been over 500 cases of negative reactions to the still legal yet dangerous drug. On the national level the U.S. Drug Enforcement Administration (DEA) recently designated certain chemicals that are present within Synthetic Marijuana to the same category that heroin and LSD are part of and further emphasizes the need to be able to test blood and urine for Synthetic Marijuana use. On the local level- The Herald Online reported that Fort Mill,...

Random Drug Testing Benefits Employers

Drug testing programs aim to prevent the hiring of drug-using applicants while deterring drug use among current employees. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), 21.4 percent of employed adults used illicit drugs within the past month. Results from the 2014 Quest Diagnostics Drug Testing Index™ (DTI) show that, in the general U.S. workforce, random urine drug test positivity rates are higher (5.7 percent) than they are for pre-employment (4.0 percent) or periodic (1.6 percent). Random or “spot” drug testing works as a drug use deterrent because these programs are conducted in an unannounced and unpredictable manner. Utilizing a random drug testing program may help employers by: Deterring current employees from engaging in drug use Preventing the need for substance abuse recovery programs Helping reduce health insurance costs Improving attendance and employee productivity Providing a safer workplace with reduced accidents However, set...